Uterine sarcoma Part II—Uterine endometrial stromal sarcoma: The TAG systematic review
- Horng, Huann-Cheng
- Wen, Kuo-Chang
- Wang, Peng-Hui
- Chen, Yi-Jen
- Yen, Ming-Shyen
- Ng, Heung-Tat
- Chang, Yen-Hou
- Chang, Yi
- Chao, Hsiang-Tai
- Chao, Kuan-Chong
- Chuang, Chi-Mu
- Ho, Chi-Hong
- Huang, Chen-Yu
- Hung, Zhi-Chen
- Jiang, Ling-Yu
- Lau, Hei-Yu
- Li, Hsin-Yang
- Lin, Chi-Yao
- Liu, Chia-Hao
- Sun, Pi-Lin
- Twu, Nae-Fang
- Wu, Hua-Hsi
- Yu, Hann-Chin
- Ju, Fong-Yuan
- Tsai, Chih-Ping
- Chang, Wen-Hsun
- Hsu, Yen-Mei
- Lee, Na-Rong
- Chen, Chih-Yao
- Chang, Ting-Chen
- Chang, Wen-Chun
- Chen, Chii-Hou
- Chen, Ruey-Jian
- Chow, Song-Nan
- Lien, Yih-Ron
- Sheu, Bor-Ching
- Torng, Pao-Ling
- Yen, Men-Luh
- Lee, Wen-Ling
- Wang, Kuan-Chin
- Chang, Chih-Long
- Chen, Chih-Ping
- Chen, Jen-Ruei
- Chen, Tze-Chien
- Huang, Jian-Pei
- Huang, Ming-Chao
- Wang, Yeou-Lih
- Chang, Cheng-Chang
- Liu, Jah-Yao
- Su, Her-Young
- Wang, Yu-Chi
- Yu, Mu-Hsien
- Huang, Lee-Wen
- Seow, Kok-Min
- Lai, Tsung-Hsuan
- Lee, Fa-Kung
- Chen, Ching-Hui
- Huang, Ben-Shian
- Hsiao, Sheng-Mou
- Sun, Hsu-Dong
- Wu, Wen-Yih
- Teng, Sen-Wen
- Chen, Kuo-Hu
- Hung, Jeng-Hsiu
- Lai, Hung-Cheng
- Yuan, Chiou-Chung
- Hsieh, Ching-Hung
- Wang, Chin-Jung
- Chang, Shing-Jyh
- Hung, Man-Jung
- Hsu, Shih-Tien
- Ke, Yu-Min
- Lu, Chien-Hsing
- Sun, Lou
- Chang, Wei-Chun
- Hung, Yao-Ching
- Lin, Wu-Chou
- Wang, Po-Hui
- Chen, Tze-Ho
- Li, Yiu-Tai
- Wu, Meng-Hsing
- Huang, Kuo-Feng
- Fu, Hung-Chun
- Chen, San-Nung
- Chiang, An-Jen
- Li, Ju-Yueh
- Lin, Li-Te
- Tsai, Hsiao-Wen
- Tsui, Kuan-Hao
DOIAbstract
AbstractEndometrial stromal tumors are rare uterine tumors (<1%). Four main categories include endometrial stromal nodule, low-grade endometrial stromal sarcoma (LG-ESS), high-grade endometrial stromal sarcoma (HG-ESS), and uterine undifferentiated sarcoma (UUS). This review is a series of articles discussing the uterine sarcomas. LG-ESS, a hormone-dependent tumor harboring chromosomal rearrangement, is an indolent tumor with a favorable prognosis, but characterized by late recurrences even in patients with Stage I disease, suggesting the requirement of a long-term follow-up. Patients with HG-ESS, based on the identification of YWHAE-NUTM2A/B (YWHAE-FAM22A/B) gene fusion, typically present with advanced stage diseases and frequently have re...
Add to ORKG